Global Computational Biology Market Size By End-User (Industry, Commercial, Academics), By Application (Preclinical Drug Development, Human Body Simulation Software), By Geographic Scope And Forecast

Computational Biology Market Size And Forecast

Computational Biology Market size was valued at USD 4,861.41 Million in 2021 and is projected to reach USD 26,313.85 Million by 2030, growing at a CAGR of 20.64% from 2023 to 2030.

The increasing penetration of research studies as a result of drug development and discovery is the primary factor driving market growth. The Global Computational Biology Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Computational Biology Market Definition

Computational systems biology is a new area of biological simulation that aims to model or replicate intracellular and intercellular activities utilizing data from genomic, proteomic, and metabolomic research. Many methodologies, such as systems of differential equations, Petri nets, cellular automata simulators, agent-based models, and pi-calculus, have emerged as a result of the requirement to describe complicated temporal and spatiotemporal phenomena at many different scales. It also shows how these techniques are being utilized to speed up medication discovery and development. The field of computational biology has grown to support the field of biology as it has become increasingly diverse and sophisticated.

Computer biologists have stepped in as motivated and capable partners in the effort to understand disease as computational power and programming have become more sophisticated. According to (NIH) Computational modeling is the application of mathematics, physics, and computer programming to simulate and analyze complicated systems using computers. The computational model has a large number of variables that describe the subject under investigation. Simulating entails changing the variables one at a time or in combination, then observing the effects. To track infectious diseases in communities, find the most effective interventions, and monitor and change actions to prevent disease spread, computational models are being employed.

During infectious disease pandemics, identifying and executing disease-controlling measures is crucial for saving lives and decreasing the burden on the healthcare system. Computational models acquire, filter, analyze, and present health data intelligently to provide doctors with disease treatment recommendations based on the unique characteristics of each patient. The systems assist in providing educated and consistent patient care as they transfer to suitable hospital facilities and departments and undergo numerous tests during their treatment. Researchers utilize computational modeling to assist in the development of pharmaceuticals that are both safe for patients and have the fewest negative effects. The method can shorten the time it takes to produce a safe and effective drug.

Global Computational Biology Market Overview

Computational biology has a wide range of applications in genomics, proteomics, pharmacogenomics, and drug development. Because these services must maintain computational biology sets in order to carry out various drug development processes, many companies turn to third-party services for drug discovery and clinical trials. The pharmaceutical industry’s emphasis on speeding up development and improving accuracy in drug development will lead to greater adoption of computational biology.

The expansion of the Computational Biology Market may be hampered by a severe shortage of trained professionals. According to (NIEHS), the lack of a link between human data and experimental data (animal and mechanistic) makes understanding these findings difficult. The human data is of the “correct” species, is linked to “real-life” exposures, and demonstrates a level of consistency that is difficult to dismiss. In terms of demonstrating a cause-and-effect link, epidemiological studies have significant limitations, whereas laboratory research is designed to do so.

Almost all laboratory findings in animals and humans, as well as the majority of mechanistic research in cells, contradict a causal relationship between ELF-EMF exposure at low levels in the environment and changes in biological function or disease status. The molecular activities are not perfect, and DNA computing contains significant errors. As the problem’s complexity increases, the likelihood of receiving an incorrect response eventually outnumbers the likelihood of receiving a correct answer.

Global Computational Biology MarketSegmentation Analysis

The Global Computational Biology Market is segmented on the basis of End-User, Application, And Geography.

Computational Biology Market, By End-User

• Industry
• Commercial
• Academics

Based on End-User, The market is classified into Industry, Commercial, and Academics. Biology and biomedical research are being revolutionized by exciting breakthroughs in biotechnology. High-throughput sequencing, high-throughput quantitative PCR, intracellular imaging, in-situ gene expression hybridization, and three-dimensional imaging techniques such as Light Sheet Fluorescence Microscopy and Optical Projection (micro)-Computer Tomography are examples of these approaches.

Given the vast amounts of complex data created by these systems, effective interpretation and even storage pose significant obstacles that necessitate novel ways. Computational science and engineering (CSE) is a relatively new discipline concerned with the development and application of computational models and simulations, often in conjunction with high-performance computing, to solve complex physical problems arising in engineering analysis and design (computational engineering) and natural phenomena (computational science).

Computational Biology Market, By Application

• Preclinical Drug Development
• Human Body Simulation Software
• Drug Discovery & Disease Modelling
• Cellular & Biological Simulation
• Others

Based on Application, The market is classified into Preclinical Drug Development, Human Body Simulation Software, Drug Discovery & Disease Modelling, Cellular & Biological Simulation, and Others. Preclinical Drug Development refers to the steps that lead from drug discovery in the lab to the start of human clinical trials. Preclinical studies can be planned to identify a lead candidate from a pool of candidates; build the best technique for novel drug scale-up; choose the best formulation; determine the route, frequency, and duration of exposure; and, finally, assist the clinical trial design. Each preclinical development package has its own set of characteristics, although they all have some in common. To define the pharmacokinetic profile and overall safety, as well as to discover toxicity patterns, rodent, and non-rodent mammalian models are used.

Computational Biology Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

On the basis of Regional Analysis, The Global Computational Biology Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. During the forecast period, the Asia Pacific region is expected to have the highest CAGR. This is primarily due to the fact that computational biology has a wide range of applications. Because these services must maintain computational biology sets in order to carry out various drug development processes, many companies turn to third-party services for drug discovery and clinical trials. The pharmaceutical industry’s emphasis on speeding up development and improving accuracy in drug development will lead to greater adoption of computational biology.

Key Players

The “Global Computational Biology Market” study report will provide valuable insight with an emphasis on the global market including some of the major players such as Accelrys, Chemical Computing Group Inc., Entelos, In-silico Biotechnology AG, Nimbus Discovery LLC, Rhenovia Pharma SAS, Certara, Compugen Ltd, Generate AG, Leadscope Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• May 2021. Certara, Inc., the world leader in biosimulation, has released new versions of its Quantitative Systems Pharmacology (QSP) Simulators for Immunogenicity (IG) and Immuno-oncology (IO) to aid in the development of biologics and cancer treatments.
• March 2021, Compugen Ltd., a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, has published a review article titled “Therapeutic Targeting of Checkpoint Receptors within the DNAM-1 Axis,” which looks at the biology and therapeutic relevance of the DNAM-1 axis in cancer immunotherapy.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.